These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37100959)

  • 41. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study.
    Lechner E; Hofer A; Leitner-Peneder G; Freynschlag R; Mair R; Weinzettel R; Rehak P; Gombotz H
    Pediatr Crit Care Med; 2012 Sep; 13(5):542-8. PubMed ID: 22622649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P; Xenikakis T; Linardakis M; Hassoulas J
    Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock.
    Oldner A; Konrad D; Weitzberg E; Rudehill A; Rossi P; Wanecek M
    Crit Care Med; 2001 Nov; 29(11):2185-93. PubMed ID: 11700420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term outcome of perioperative low cardiac output syndrome in cardiac surgery: 1-year results of a multicenter randomized trial.
    Zangrillo A; Lomivorotov VV; Pisano A; Calabrò MG; Belletti A; Brazzi L; Grigoryev EV; Guarracino F; Monaco F; Garofalo E; Crivellari M; Likhvantsev VV; Fominskiy EV; Paternoster G; Yavorovskiy A; Pasyuga VV; Oriani A; Lembo R; Bianchi A; Scandroglio AM; Abubakirov MN; Di Tomasso N; Landoni G;
    J Crit Care; 2020 Aug; 58():89-95. PubMed ID: 32402931
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interventions for non-oliguric hyperkalaemia in preterm neonates.
    Vemgal P; Ohlsson A
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005257. PubMed ID: 17253550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interventions for non-oliguric hyperkalaemia in preterm neonates.
    Vemgal P; Ohlsson A
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD005257. PubMed ID: 22592703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary hypertension in extremely preterm infants: a call to standardize echocardiographic screening and follow-up policy.
    Arjaans S; Zwart EAH; Roofthooft M; Kooi EMW; Bos AF; Berger RMF
    Eur J Pediatr; 2021 Jun; 180(6):1855-1865. PubMed ID: 33528615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of prophylactic levosimendan in high-risk valve surgery patients.
    Ersoy O; Boysan E; Unal EU; Yay K; Yener U; Cicekcioglu F; Katircioglu F
    Cardiovasc J Afr; 2013 Aug; 24(7):260-4. PubMed ID: 24217302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Levosimendan versus Dobutamine in Patients with Moderate to Severe Left Ventricular Dysfunction Undergoing Off-pump Coronary Artery Bypass Grafting: A Randomized Prospective Study.
    Kandasamy A; Simon HA; Murthy P; Annadurai M; Ali MM; Ramanathan G
    Ann Card Anaesth; 2017; 20(2):200-206. PubMed ID: 28393781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.
    Hillestad V; Kramer F; Golz S; Knorr A; Andersson KB; Christensen G
    J Appl Physiol (1985); 2013 Nov; 115(10):1572-80. PubMed ID: 24072410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors and associated clinical outcomes of low cardiac output syndrome following cardiac surgery: insights from the LEVO-CTS trial.
    Kochar A; Zheng Y; van Diepen S; Mehta RH; Westerhout CM; Mazer DC; Duncan AI; Whitlock R; Lopes RD; Argenziano M; de Varennes B; Alexander JH; Goodman SG; Fremes S
    Eur Heart J Acute Cardiovasc Care; 2022 Nov; 11(11):818-825. PubMed ID: 36156131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A systematic review on levosimendan in paediatric patients.
    Silvetti S; Silvani P; Azzolini ML; Dossi R; Landoni G; Zangrillo A
    Curr Vasc Pharmacol; 2015; 13(1):128-33. PubMed ID: 25440597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Levosimendan for Perioperative Cardioprotection: Myth or Reality?
    Santillo E; Migale M; Massini C; Incalzi RA
    Curr Cardiol Rev; 2018; 14(3):142-152. PubMed ID: 29564979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study.
    García-González MJ; Jorge-Pérez P; Jiménez-Sosa A; Acea AB; Lacalzada Almeida JB; Ferrer Hita JJ
    Cardiovasc Ther; 2015 Aug; 33(4):193-9. PubMed ID: 25959786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
    Follath F; Cleland JG; Just H; Papp JG; Scholz H; Peuhkurinen K; Harjola VP; Mitrovic V; Abdalla M; Sandell EP; Lehtonen L;
    Lancet; 2002 Jul; 360(9328):196-202. PubMed ID: 12133653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
    Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preconditioning with levosimendan reduces postoperative low cardiac output in moderate-severe systolic dysfunction patients who will undergo elective coronary artery bypass graft surgery: a cost-effective strategy.
    Jiménez-Rivera JJ; Álvarez-Castillo A; Ferrer-Rodríguez J; Iribarren-Sarrías JL; García-González MJ; Jorge-Pérez P; Lacalzada-Almeida J; Pérez-Hernández R; Montoto-López J; Martínez-Sanz R
    J Cardiothorac Surg; 2020 May; 15(1):108. PubMed ID: 32448319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of Levosimendan Versus IABP in Patients with Poor Left Ventricular Function Undergoing Coronary Artery Bypass Graft Surgery.
    Omar A; Eldegwy M; Allam M; Rouchdy A; Soliman SAH; Dawou O; Elshihy E
    Heart Surg Forum; 2020 Feb; 23(1):E093-E097. PubMed ID: 32118551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines.
    Delle Karth G; Buberl A; Geppert A; Neunteufl T; Huelsmann M; Kopp C; Nikfardjam M; Berger R; Heinz G
    Acta Anaesthesiol Scand; 2003 Nov; 47(10):1251-6. PubMed ID: 14616323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure.
    Kerbaul F; Gariboldi V; Giorgi R; Mekkaoui C; Guieu R; Fesler P; Gouin F; Brimioulle S; Collart F
    Crit Care Med; 2007 Aug; 35(8):1948-54. PubMed ID: 17568324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.